CLASS I ONGOING Device recall · Reported 20 Nov 2024 · FDA Enforcement Report

Monoject U-100 Insulin Syringe Luer-Lock with Tip Cap Soft Pack recalled

Cardinal Health 200 is recalling Monoject U-100 Insulin Syringe Luer-Lock with Tip Cap Soft Pack, distributed nationwide in the US. The recall was initiated on 25 Sep 2024 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesUDI/DI 10192253034783 (EA), Lot Number 221201, exp. 2027-11-30; UDI/DI 20192253034780 (BX), Lot Number 230201, exp. 2028-01-31; UDI/DI 50192253034781 (CS), Lot Number 230202,exp. 2028-02-01
Quantity recalled371,326 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0310-2025
FDA event ID
95487
Recalling firm
Cardinal Health 200, Waukegan, IL
Classification
Class I
Status
Ongoing
Recall initiated
25 Sep 2024
FDA classified
8 Nov 2024
Reported
20 Nov 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

25 Sep 2024Recall initiated by company
8 Nov 2024Classified by FDA+44 days
20 Nov 2024Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Certain lots of listed lots of Cardinal Health Monoject U-100 1 mL Insulin Syringe Luer-Lock with Tip Cap Soft Pack have demonstrated incompatibility with needleless Intravenous (IV) connectors. Cardinal Health recommends that they not be used for administration of IV push insulin via needleless connector.

Product as listed by the FDA

Monoject U-100 1 mL Insulin Syringe Luer-Lock with Tip Cap Soft Pack, REF 1188100777

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Certain lots of listed lots of Cardinal Health Monoject U-100 1 mL Insulin Syringe Luer-Lock with Tip Cap Soft Pack have demonstrated incompatibility with needleless Intravenous (IV) connectors. Cardinal Health recommends that they not be used for administration of IV push insulin via needleless connector.

Which lots are affected?

UDI/DI 10192253034783 (EA), Lot Number 221201, exp. 2027-11-30; UDI/DI 20192253034780 (BX), Lot Number 230201, exp. 2028-01-31; UDI/DI 50192253034781 (CS), Lot Number 230202,exp. 2028-02-01

Where was it sold?

Nationwide

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Cardinal Health 200

All 283

Other Syringes & Needles recalls

All 1,060